AusPAR: Arexvy
Australian Public Assessment Report
Device/Product Name
Arexvy
Active ingredients
Recombinant respiratory syncytial virus pre-fusion F protein
AusPAR Date
Published
Submission Number
PM-2022-05281-1-2
Submission Type
New Biological Entity (New Vaccine)
Decision
Approved